The change of drug utilization in China's public healthcare institutions under the "4 + 7" centralized drug procurement policy: Evidence from a natural experiment in China

• Hauptverfasser: Jiancheng Lu (Verfasst von), Hongfei Long (Verfasst von), Yuan Shen (Verfasst von), Jing Wang (Verfasst von), Xin Geng (Verfasst von), Ying Yang (Verfasst von), Zongfu Mao (Verfasst von), Jinghua Li (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: Improving drug accessibility and rational drug use are major challenges for China's healthcare reform. In 2018, the Chinese government introduced a novel nationwide policy of centralized drug procurement for off-patent drugs, focusing on improving drug utilization patterns of public...